idazoxan has been researched along with Schizophrenia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artigas, F; Bortolozzi, A; Masana, M | 1 |
| Dean, B | 1 |
| Hong, WW; Litman, RE; Pickar, D; Potter, WZ; Su, TP; Weissman, EM | 1 |
| Hong, WW; Hsiao, JK; Litman, RE; Pickar, D; Potter, WZ; Su, TP; Weissman, EM | 1 |
| Hong, WW; Litman, RE; Pickar, D; Potter, WZ; Su, TP | 1 |
| Fagerquist, MV; Hertel, P; Svensson, TH | 1 |
3 trial(s) available for idazoxan and Schizophrenia
| Article | Year |
|---|---|
Idazoxan, an alpha 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Dioxanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Humans; Idazoxan; Male; Pilot Projects; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1993 |
Clinical response to clozapine in patients with schizophrenia.
Topics: Clozapine; Dioxanes; Double-Blind Method; Drug Therapy, Combination; Fluphenazine; Hospitalization; Humans; Idazoxan; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |
Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine.
Topics: Adrenergic alpha-Antagonists; Adult; Antipsychotic Agents; Clozapine; Dioxanes; Double-Blind Method; Drug Therapy, Combination; Female; Fluphenazine; Humans; Idazoxan; Imidazoles; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1996 |
3 other study(ies) available for idazoxan and Schizophrenia
| Article | Year |
|---|---|
Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
Topics: Adrenergic Agents; Animals; Antipsychotic Agents; Cognition; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Electric Stimulation; Haloperidol; Idazoxan; Male; Microdialysis; Molecular Targeted Therapy; Morpholines; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Reboxetine; Schizophrenia; Synaptic Transmission; Ventral Tegmental Area | 2011 |
[3H]RX 821002 in human dorsolateral prefrontal cortex: no changes in postmortem tissue from subjects with schizophrenia.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Benzodiazepines; Binding Sites; Clozapine; Female; Hippocampus; Humans; Idazoxan; Male; Middle Aged; Olanzapine; Postmortem Changes; Prefrontal Cortex; Schizophrenia; Serotonin Antagonists | 2003 |
Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Conditioning, Psychological; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Idazoxan; Nucleus Accumbens; Prefrontal Cortex; Raclopride; Rats; Receptors, Adrenergic, alpha-2; Salicylamides; Schizophrenia | 1999 |